Changes of colonic bacterial composition in Parkinson's disease and other neurodegenerative diseases
Open accessPublished version of a preprint
The DOI matches its Crossref record; 102 of the 103 references it cites were found in a registry or an index.
Abstract
In recent years evidence has emerged that neurodegenerative diseases (NDs) are strongly associated with the microbiome composition in the gut. Parkinson’s disease (PD) is the most intensively studied neurodegenerative disease in this context. In this review, we performed a systematic evaluation of the published literature comparing changes in colonic microbiome in PD to the ones observed in other NDs including Alzheimer’s disease (AD), multiple system atrophy (MSA), multiple sclerosis (MS), neuromyelitis optica (NMO) and amyotrophic lateral sclerosis (ALS). To enhance the comparability of different studies, only human case-control studies were included. Several studies showed an increase of Lactobacillus, Bifidobacterium, Verrucomicrobiaceae and Akkermansia in PD. A decrease of Faecalibacterium spp., Coprococcus spp., Blautia spp., Prevotella spp. and Prevotellaceae was observed in PD. On a low taxonomic resolution, like the phylum level, the changes are not disease-specific and are inconsistent. However, on a higher taxonomic resolution like genus or species level, a minor overlap was observed between PD and MSA, both alpha synucleinopathies. We show that standardization of sample collection and analysis is necessary for ensuring the reproducibility and comparability of data. We also provide evidence that assessing the microbiota composition at high taxonomic resolution reveals changes in relative abundance that may be specific to or characteristic of one disease or disease group, and might evolve discriminative power. The interactions between bacterial species and strains and the co-abundances must be investigated before assumptions about the effects of specific bacteria on the host can be made with certainty.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Akkermansia utilize mucin as a source of energy and may therefore reduce barrier function and increase exposure to more microbial substrates across the epithelial lining.44”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [44]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 1×
“There are up to 100 times more microbial genes, named the microbiome, than human genes in one individual [7].”
BackgroundKalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Human Genetics Shape the Gut Microbiome
Goodrich, J. K., Waters, J. L., Poole, A. C., Sutter, J. L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J. T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.053 · Cited by 3,164 · cited 1×
“Since the Faecalibacterium prausnitzi species include a high diversity of strains, a strain-dependent classification and investigation would improve insight into the beneficial and harmful effects on the host [79].”
BackgroundMicrobiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457
Gut microbiome alterations in Alzheimer’s disease
Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., Carlsson, C. M., Asthana, S., Zetterberg, H., Blennow, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13601-y · Cited by 2,137 · cited 2×
“Other methodical choices, like choosing between the different bead beating cell lysis instruments before metagenome analysis, influence this ratio up to threefold in favour of Bacteroides [55].”
BackgroundAre We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans
Sender, R., Fuchs, S., & Milo, R. (2016) · Cell · doi:10.1016/j.cell.2016.01.013 · Cited by 2,050
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Research works printed but not linked: 1
- He Z. Microarrays Caister Academic Press Wymondham, UK 2014
Cited by
Items 201–300 of 306
Gut bacteria-derived metabolites and their implications in mental health and neurological diseases
Srivastava, R., & Gupta, M. K. (2025) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-025-04656-5 · Cited by 10
“Recent studies showed that gut dysbiosis impacts PD, which is the neurodegenerative con - dition that causes movement-related symptoms such as bra-dykinesia and tremors (Gerhardt and Mohajeri 2018 ; Dong et al. 2022).”
InfluentialXu, X., Lubomski, M., Holmes, A. J., Sue, C. M., Davis, R. L., Müller, S., & Yang, J. Y. H. (2023) · Microbiome · doi:10.1186/s40168-023-01475-4 · Cited by 11
“These bacteria are known to impact immune response and constipation, with many studies reporting an overrepresentation in PD [39, 40, 42, 53].”
BackgroundEmerging mechanisms of organ crosstalk: The role of oxylipins
Fisk, H. L., & Shaikh, S. R. (2024) · Nutrition Bulletin · doi:10.1111/nbu.12726 · Cited by 11
“Changes to bacterial genera and phyla are seen in individuals living with Parkinson's disease (Gerhardt & Mohajeri, 2018; Sun & Qin, 2018), amyotrophic lateral sclerosis, multiple sclerosis and autism spectrum disorder (Saxami et al., 2023; Varesi et al., 2022).”
Yue, M., Chen, T., Chen, W., Wei, J., Liao, B., Zhang, J., Li, F., Hong, D., & Fang, X. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00702 · Cited by 11
“In addition to synucleinopathy in the brain and intestines, inflammation is also an important pathological manifestation of PD. Zhao et al. (2021a) reported that engineered probiotics increase the integrity of the colonic epithelium, so next we investigated the association between the intestinal…”
Frolova, S. G., Vatlin, A. A., Pospelova, I., Mitkin, N. A., Kulieva, G. A., & Pavshintsev, V. V. (2025) · Toxics · doi:10.3390/toxics13090769 · Cited by 12
“Decreased abundances of Ruminococcaceae , Blautia , Bacteroides , and Lactobacillus in Cd-exposed fish parallelled patterns linked to aging and neurodegenerative conditions like Parkinson’s [114] and Alzheimer’s diseases [115] in mammals.”
Wang, Y.-W., Yao, T., Lin, Y., Ge, H., Huang, B., Gao, Y., & Wu, J. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1327083 · Cited by 10
“…has been found to be more scarce in the gut of Parkinson ’ s disease patients and that rosacea and Parkinson ’ s disease are epidemiologically linked, further exploration of the role of this bacterium in the brain – gut – skin axis is warranted (Egeberg et al., 2016; Gerhardt and Mohajeri, 2018).”
BackgroundThe role of gut-derived short-chain fatty acids in Parkinson's disease
Saadh, M. J., Mustafa, A. N., Mustafa, M. A., Renuka Jyothi, S., Dabis, H. K., Prasad, G. V. S., Mohammad, I. J., Adnan, A., & Idan, A. H. (2024) · Neurogenetics · doi:10.1007/s10048-024-00779-3 · Cited by 9
“Recent research has established a link between GM abnormalities and the development of PD. Compared to healthy individuals, patients with PD have a distinct GM [283, 284].”
Shang, M., Ning, J., Zang, C., Ma, J., Yang, Y., Jiang, Y., Chen, Q., Dong, Y., Wang, J., Li, F., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.011 · Cited by 11
“It is produced by the intestinal flora, especially highly expressed in the Bifidobacterium and Lactobacillus genus, which are strongly correlated to gut dysbiosis of PD.”
Understanding the potential causes of gastrointestinal dysfunctions in multiple system atrophy
Craig, C. F., Finkelstein, D. I., McQuade, R. M., & Diwakarla, S. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106296 · Cited by 8
Gut Microbiota in Health and Diseases
Krga, I., & Glibetić, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00045-0 · Cited by 12
An Overview of Gastrointestinal Dysfunction in Parkinsonian Syndromes
Talman, L. S., & Safarpour, D. (2023) · Seminars in Neurology · doi:10.1055/s-0043-1771461 · Cited by 8
Jiang, W., Lu, G., Qiao, T., Yu, X., Luo, Q., Tong, J., Fan, S., Chai, L., Gao, D., Wang, R., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21463 · Cited by 8
“…Blautia, Subdoligranulum, Anae-rostipes, unclassified_f__Lachnospiraceae, Fusicatenibacter, Butyricicoccus, and Coprococcus_3 , in HT and GD patients were significantly decreased compared to controls, consistent with previous studies presenting drops in these microbiota in other diseases [24 – 26].”
Lee, J., & Allen, J. (2019) · Health Care For Women International · doi:10.1080/07399332.2019.1669606 · Cited by 8
Ovalle, A., López, E., Sierralta, J. A., Paricio, N., & Garrido, D. A. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00797-5 · Cited by 7
“Also, the abundance of butyrate-producing bacteria, such as Roseburia and Faecalibacterium spp., was signi fi cantly reduced in PD patients compared to healthy controls 31 .”
Gut microbiota and parkinson's disease
Huarcaya, L. R. D., Mohammadi, M. R., & Ríos, M. F. D. (2021) · Cellular Molecular and Biomedical Reports · doi:10.55705/cmbr.2021.410426.1165 · Cited by 7
Kumar, H., Roy, A., Choudhury, S., Banerjee, R., Basu, P., Mondal, B., Sarkar, S., Anand, S. S., & Dey, S. (2023) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_823_22 · Cited by 8
“[18] Studies have shown that, living near water body and related BMAA exposure might be responsible for protein misfolding and aggregation, resulting in neuro‐inflammation in PD.[19] Based on these considerations we hypothesize that; past dietary and environmental chemicals‐toxins might impact the incidence of PD in t…”
BackgroundThe Anatomy and Clinical Significance of Sensory Disturbance in Parkinson's Disease
Ma, B., Zhang, J., Cui, Y., & Gao, H. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2203056 · Cited by 8
Mohammad, S. I., Hammood, Y. M., Vasudevan, A., Uthirapathy, S., Ballal, S., Sabarivani, A., Mishra, S., Nathiya, D., Al‐qaim, Z. H., & KADHIM, A. J. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05447-7 · Cited by 7
“In manifest HDGECs, lower abundance of Eubac-terium hallii ( E. hallii ) correlated with more severe motor signs [186].”
Nyam, T.-T. E., Wee, H.-Y., Chiu, M., Tu, K.-C., Wang, C.-C., Yeh, Y., & Kuo, C.-L. (2024) · Neurocritical Care · doi:10.1007/s12028-024-01997-1 · Cited by 10
Toxicity mechanism of sevoflurane in neural stem cells of rats through DNA methylation
Wang, K., Tian, Y., Zhang, Y., Li, X., Wei, X., Hu, H., & Xu, S. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7553 · Cited by 6
“A variety of related diseases are induced when the number of nerve cells gradually declines (1,2), such as Alzheimer's disease, Parkinson's disease, cerebellar atrophy and other neurodegenerative diseases (3).”
BackgroundSCFA producing bacteria shape the subtype of ADHD in childrenPreprint
Fan, C., Li, S., Wang, R., Fan, X., Liang, A., & Qi, K. (2019) · Research Square · doi:10.21203/rs.2.16337/v1 · Cited by 6
“The key members of Ruminococcaceae showed a confirmed decrease and were negatively correlated to disease duration in some neurodegenerative diseases, such as Parkinson’s disease (PD), multiple system atrophy (MSA), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) [24].”
BackgroundLactobacillaceae and Parkinson's disease: An apparent paradox
van der Maden, M. M., Verbeek, M. M., & Beckers, M. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x241312401 · Cited by 9
“Lactobacillaceae is one of the bacterial families of which abundance is increased in PD. 14 An altered gut microbial composition in PD has also been linked to a pro-in fl ammatory state of the intestines.”
Microbiome‐derived metabolites in substance use disorders: Mechanisms and implications
Koperska, M., & Kiraly, D. D. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15416 · Cited by 5
Treating autism spectrum disorder by intervening with gut microbiota
Tu, T., & Zhao, C. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001469 · Cited by 6
Microbial Trojan Horses: Virulence Factors as Key Players in Neurodegenerative Diseases
Grahl, M. V. C., Hohl, K. S., Smaniotto, T. Â., & Carlini, C. R. (2025) · Molecules · doi:10.3390/molecules30030687 · Cited by 5
“This, in turn, may promote neuroinflammation and contribute to the neurodegeneration observed in these diseases [75–77 Among the bacteria in this genus, certain species stand out: Prevotella corpi , which participates in the degradation of complex polysaccharides and the production of short-chain…”
InfluentialSzablewski, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00065-6 · Cited by 5
IMPACT: interpretable microbial phenotype analysis via microbial characteristic traits
Mechtersheimer, D., Ding, W., Xu, X., Kim, S., Sue, C. M., Cao, Y., & Yang, J. Y. H. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae702 · Cited by 6
Gut Microbes in Parkinson's Disease
Markidi, A., Elford, J. D., Berkers, C. R., Kraneveld, A. D., & Perez‐Pardo, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99971-7.00002-3 · Cited by 4
Ko, Y., Kim, S., Pan, C., & Park, K. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3100893 · Cited by 4
Bali, P., Lal, P., Sivapuram, M. S., Kutikuppala, L. V. S., Avti, P., Chanana, A., Kumar, S., & Anand, A. (2024) · Neuroepidemiology · doi:10.1159/000538416 · Cited by 5
“The mechanism gains prominence by the further presence of Lewy bodies in the human gut [235, 236].”
The epidemiology of animal bite, scratch, and other potential rabies exposures, Louisiana.
Balsamo, G. A., Ratard, R. C., & Claudet, A. L. (2009) · PubMed · Cited by 6
Kohn, N., Szopinska-Tokov, J., Llera, A., Beckmann, C. F., Vásquez, A. A., & Aarts, E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.25.266122 · Cited by 5
Wang, N., Pan, X., Hong-kang, Z., Guo, Y., & Qian, H. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.03.442390 · Cited by 4
The Role of Gut Microbiota in Aging-Associated Diseases
Mobed, A. (2023) · International Journal of Aging · doi:10.34172/ija.2023.e12 · Cited by 3
Prinelli, F., Mastropietro, A., Bernini, S., Camboni, T., Consolandi, C., Conti, S., Costa, A. C., Ramusino, M. C., Jesuthasan, N., Pansarasa, O., et al. (2026) · Clinical Nutrition · doi:10.1016/j.clnu.2026.106585 · Cited by 3
Oso, T. A., Okesanya, O. J., Adebayo, U. O., Obadeyi, K. B., Ayelaagbe, O. B., Talabi, O. A., Adewole, P. D., Anorue, C. O., Ahmed, M. M., Talabi, O., et al. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261436287 · Cited by 4
Guo, H., Qin, X., Tang, Y., Wang, C., Luo, Q., Gao, H., & Gao, Q. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117051 · Cited by 4
Ketter-Katz, H., Saeed, R., Sher, I., Altmann, G., Shadi, T., Dallasheh, S., Lustig-Barzelay, Y., Sabo, A., Jejelava, G., Hadar, R., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-70960-z · Cited by 4
“While Clostridia Clostridiales taxa were shown to be increased in Neuromyelitis Optica (NMO) patients 58 , they were shown to decrease in Parkinson’s disease (PD) patients 57,59 .”
BackgroundAbouelmagd, M. E., Kassar, O., Hassan, A., AbdelMeseh, M., Mady, A., & Makhlouf, H. A. (2025) · Neuroepidemiology · doi:10.1159/000545218 · Cited by 3
“Heng et al. [39] found alterations in the gut microbiome in fl uconazole-treated patients, especially important bacteriome, leading to increased Firmicutes and Proteobacteria prevalence which their increase was already noticed in PD patients compared to healthy controls [40].”
Intestinal dysbiosis leads to the reduction in neurochemical production in Parkinson’s disease (PD)
Kumar, R., & Kumar, R. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.03.004 · Cited by 3
Roy, J. R., Janaki, C. S., Rajagopal, P., & Jayaraman, S. (2024) · Springer eBooks · doi:10.1007/978-981-99-8803-7_5 · Cited by 3
Monselise, E. B.-I., Vyazmensky, M., Scherf, T., Batushansky, A., & Fishov, I. (2024) · Scientific Reports · doi:10.1038/s41598-024-68645-8 · Cited by 4
Hernández-García, J., Muro-Reche, P., & Orenes‐Piñero, E. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05271-6 · Cited by 5
“…healthy controls with human microbiota had no effect, suggesting that a specific interaction with the host may influence the development of a genetically derived trait, since healthy intestinal development requires microbiota colonisation and antibiotic treatments to influence host physiology [43].”
Nutrition and Neuroinflammation
Na’Allah, A., Asuku, A. O., AbdulRazaq, A., Ambali, O. A., Oyeleke, M. B., & Odetayo, A. F. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-1983-5_3 · Cited by 2
Wu, L., Li, S., Han, F., Guo, J., Zhang, X., & Xu, L. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1801367 · Cited by 3
“Ellagitannins (found in pomegranate, walnuts, strawberries) are not absorbed but are hydrolyzed and metabolized by specific gut bacteria (e.g., Gordonibacter spp.) to form urolithins (Gerhardt and Mohajeri, 2018).”
Su, T., Lang, Y., Ren, J., Yin, X., Zhang, W., & Cui, L. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04376-1 · Cited by 2
“In recent years, the interaction between the gut microbiome and neurodegenerative diseases such as Parkinson’s disease (PD) and Alzheimer’s disease (AD) has garnered widespread attention in the scientific community [32–34].”
Coelho, I., Duarte, N., Macedo, M. P., & Penha‐Gonçalves, C. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/857078 · Cited by 2
Schmit, K. J., Sciortino, A., Aho, V. T. E., Garcia, P., Rodriguez, B. P., Thomas, M. H., Gérardy, J., Halder, R., Cialini, C., Heurtaux, T., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.21.485143 · Cited by 2
Gut microbiota: role of biofilms in human health
Jha, D., & Kumar, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19252-4.00009-2 · Cited by 1
Introduction to Gut Microbiota and Its Role in Health and Diseases
Sharma, S., Hussain, M. S., Khan, Y., & Maqbool, M. (2025) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-031-86065-2_2 · Cited by 1
Associations between gut microbiota and multiple system atrophy: a Mendelian randomization study
Wang, D., Zhao, Y.-Y., & Huang, Y. M. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13491-5 · Cited by 1
“Moreover, specific genera within Lachnospiraceae , including Blautia and Dorea , were found reduced in patients with MSA [12, 13].”
Joshi, D., Chauhan, K., Oberoi, H. S., Kumar, D., & Taneja, N. K. (2026) · Discover Biotechnology · doi:10.1007/s44340-026-00053-2 · Cited by 2
Gut Microbiome Changes in Preclinical Alzheimer’s Disease
Dissanayaka, S. U., Rainey‐Smith, S. R., Sohrabi, H. R., Jayasinghe, T. N., Ho, V., Jayasena, V., Taddei, K., Masters, C. L., Martins, R. N., & Fernando, W. M. A. D. B. (2026) · Nutrients · doi:10.3390/nu18152469 · Cited by 1
“Alterations in gut microbial composition and function have been reported across several neurodegenerative disorders, including Parkinson’s disease (PD) and AD [140,141], with PD included here as a comparative example rather than a primary focus of this review.”
Dehnow, A. H., & Krishna, M. S. (2020) · Advances in Zoology and Botany · doi:10.13189/azb.2020.080202 · Cited by 2
Microbiota and Parkinson's disease (overview)
Tyutina, R. R., Pilipovich, A. A., Голубев, В. Л., & Danilov, A. B. (2020) · Medical alphabet · doi:10.33667/2078-5631-2020-1-10-14 · Cited by 2
“В частности, изменения в составе кишечного микробиома были описаны при различных нейродегенеративных заболеваниях, в том числе при БП [33].”
Microbiota as a Regulator of Circadian Rhythms—Special Focus on Sleep and Metabolism
Parkar, S. G., & Blum, D. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00109-1 · Cited by 1
Topical Aspects of Intestinal Dysbiosis in Children
Kozlovsky, A. A. (2023) · Педиатрия Восточная Европа · doi:10.34883/pi.2022.10.4.012 · Cited by 1
Exploring the Impact of Microbial Invasion on the Diseases Involving Gut-Brain Axis in Animals
Jain, P., Pundir, R. K., & Pandey, R. P. (2023) · Livestock diseases and management · doi:10.1007/978-981-99-2209-3_11 · Cited by 1
田, 格. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.142347 · Cited by 1
Role of oral-gut-brain axis in psychiatric and neurological disorders
Duan, Z.-M., & Wu, L.-F. (2024) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v32.i12.878 · Cited by 1
Comamonas aquatica diet inhibits TIR-1/SARM1-induced axon degeneration by providing vitamin B12
O'Connor, L., Kang, W. K., Vo, P., Spinelli, J. B., Alkema, M. J., & Byrne, A. B. (2026) · Cell Reports · doi:10.1101/2024.11.20.622298 · Cited by 1
Differential abundance analyses of human microbiota in Parkinson’s disease
Aho, V. T. E. (2019) · Helda - University of Helsinki Institutional Repository
Diet, Gut Microbiome and Multiple Sclerosis
Sell, L. B., & Ochoa‐Repáraz, J. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016070-00302
Kinstler, S. (2019) · Lincoln (University of Nebraska)
Exploring the Effects of Gut Microbiota With the Association of Parkinson’s Disease
Babić, K. (2019) · Blue Tiger Commons (Lincoln University - Missouri)
Human Gut Microbiota: Friend or Foe?
Pliszka, M., & Szablewski, L. (2020) · OBM Hepatology and Gastroenterology · doi:10.21926/obm.hg.2003050 · Cited by 1
Nazario, L. R. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.130756082
Novindra, Q. A., Alifah, F. G., & Syarifah, N. A. (2021) · Al-Iqra Medical Journal Jurnal Berkala Ilmiah Kedokteran · doi:10.26618/aimj.v4i1.4980
Microbiome Management of Neurological Disorders
Ortíz, G. G., Bitzer-Quintero, O. K., Niño, C. L. C., Ramírez-Jirano, L. J., González-Usigli, H., Pacheco-Moisés, F. P., Torres-Mendoza, B. M., Mireles-Ramírez, M. A., Hernández-Cruz, J. J., & Delgado-Lara, D. L. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00003-6
Shared microbial community changes in female rats and humans with Rett syndromePreprint
Gallucci, A., Patterson, K. C., Weit, A. R., Pol, W. V. D., Dubois, L. G., Percy, A. K., Morrow, C. D., Campbell, S. L., & Olsen, M. L. (2019) · doi:10.21203/rs.2.19018/v1
“Notably, Faecalibacterium and Lachnospiraceae are also increased in healthy controls relative to patients with Parkinson disease (47), another neurological disorder in which the role of the gut/brain axis appears increasingly important.”
BackgroundDutra, J., Fung, M., Ling, M. X., & Zhi, R. L. (2021) · Open Collections · doi:10.14288/ujemi.v26.195455
Multifactor Progression of Parkinson's Disease: Role of Diet and Exposure to Microbiome-Borne CurliPreprint
Schmit, K. J., Sciortino, A., Aho, V. T. E., Garcia, P., Rodriguez, B. P., Thomas, M. H., Gérardy, J., Acha, I. B., Halder, R., Cialini, C., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4182866
Minelli, A., & Palma, M. D. (2022) · PNEI REVIEW · doi:10.3280/pnei2022-002004
Norouzy, A., Mohamadinarab, M., & Kalayeh, H. M. G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89834-8.00046-5
The Effects of Gut Dysbiosis via Bacteriophages and its Role in Parkinson's Disease
Mazhar, S. F. (2023) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2023-15758 · Cited by 1
Insights in the Cross-Talk Between Microbiota-Gut-Brain Axis: A Focus on Alzheimer’s Disease
Soni, T., Jawanda, I. K., Kumari, S., & Prabha, V. (2023) · Springer eBooks · doi:10.1007/978-981-99-3126-2_22
Gonçalves, I. D. O., da Silva, P. R. R., Vieira, L. F. M., Maia, M. G. F., Barroso, J. M. D. C., Prado, M. E. O., dos Santos, J. A., & Tavares, P. G. B. (2024) · Revista Foco · doi:10.54751/revistafoco.v17n4-050
Considering the influence of diet on neurodegeneration
Wankhade, S., Mude, G. S., & Ingale, S. (2024) · Multidisciplinary Reviews · doi:10.31893/multirev.2025131
“The stomach and its relationship with the CNS have come under scrutiny, as it was discovered that the pathology of PD starts in the caudal region of the CNS (Gerhardt & Mohajeri, 2018).”
The gut-microbiota and neurodegenerative disorders: What is the interplay?
Aljumayi, H., Khalil, N. A., & Alrasheedi, A. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00006-3
Zhao, Z., Ning, J., 鲍秀琦, Shang, M., Ma, J., Li, G., & Zhang, D. (2021) · Figshare · doi:10.6084/m9.figshare.17030693
Zhao, Z., Ning, J., 鲍秀琦, Shang, M., Ma, J., Li, G., & Zhang, D. (2021) · Figshare · doi:10.6084/m9.figshare.17030702
Zhao, Z., Ning, J., 鲍秀琦, Shang, M., Ma, J., Li, G., & Zhang, D. (2021) · Figshare · doi:10.6084/m9.figshare.17030708
Wu, G., Zhao, N., Zhang, C., Lam, Y. Y., & Zhao, L. (2021) · Figshare · doi:10.6084/m9.figshare.13843693
Chen, Q., Zhong, L., Zhou, C., Feng, Y., Liu, Q.-X., Zhou, D., Lu, X., Du, G.-S., Jian, D., Luo, H., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13468249
Schmit, K. J. (2022) · Open Repository and Bibliography (University of Luxembourg)
Wellman, R. (2024) · UCL Discovery (University College London)
Htoo, Z. W. (2022) · K-State Research Exchange (Kansas State University)
Orion Microbiome Database: mapping constellations in the microbiome universePreprint
Wu, G., Tang, Y., Du, G., Heibeck, N., Scaliogtti, J., Francis, W., & Tang, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.05.704118
“In the context of PD, these results reinforce the emerging view that the gut microbiome plays a role in disease pathophysiology, potentially through pathways involving SCFA metabolism, mucosal integrity, and immune signalling (70,71).”
Hasegawa, T., Iwai, S., Ikeda, H. O., Miyaoka, D., Sato, N., Fujimoto, K., Wei, X., Kusaka, M., Miyata, M., Numa, S., et al. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.2.27 · Cited by 2
Gözüperk, E., & Bakırel, T. (2026) · Journal of Istanbul Veterinary Sciences · doi:10.30704/http-www-jivs-net.1909156
Medouni‐Haroune, L., Medouni‐Adrar, S., Messaoudene, L., Negrichi, S., Bouiche, C., Sahraoui-Remini, Y., Allam, A., Meghlaoui, Z., Mouhoubi, K., Abbou, A., et al. (2026) · Food & Function · doi:10.1039/d6fo00371k
Noor, U., Khan, I., Zheng, W.-F., Khan, I., & Li, S. (2026) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2026.06
Gao, S., Wang, Z., Xie, A.-H., Wu, J.-X., Li-yun, Q., Chen, T., & Chen, X. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1907570
“Research has reported increased trend in abundance of the Actinobacteriota in PD individuals (43–45), which may be related to oxidative stress or metabolic dysregulation caused by gut inflammation (46, 47).”
Balsamo, J. M., & Bess, E. N. (2026) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.6c00110
Xu, Y., Li, Q., Chen, X., Zhang, X., & Xie, J. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109771
Du, Y., Li, Q., Yang, F., Zhang, B., Lei, M., Zhao, D., Xu, X., Yang, H., & Lian-kui, W. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6c08126
Metadata
- Authors
- Gerhardt, S., & Mohajeri, M. H.
- Affiliations
- University of Zurich (CH)
- Corresponding author
- Mohajeri, M. Hasan
- ORCID
- Mohajeri, M. Hasan
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2018-06-01
- Volume
- 10
- Issue
- 6
- Pages
- 708
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6024871
- OpenAlex
- W2800577687
- Cited by
- 298
- References
- 103
- Citations by year
- 2026: 18 · 2025: 19 · 2024: 35 · 2023: 41 · 2022: 46 · 2021: 70 · 2020: 36 · 2019: 29 · 2018: 3
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Multiple Sclerosis Society
- EU Joint Programme – Neurodegenerative Disease Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- Parkinson's disease, gut microbiota, colonic microbiota, neurodegenerative diseases, Alzheimer's disease, multiple system atrophy, multiple sclerosis, neuromyelitis optica, amyotrophic lateral sclerosis, Lactobacillus, Bifidobacterium, Akkermansia, Verrucomicrobiaceae, Faecalibacterium, Prevotella, synucleinopathies
- MeSH terms
- Gastrointestinal Microbiome, Humans, Intestinal Mucosa, Parkinson Disease, Research Design, Severity of Illness Index, Reproducibility of Results, Neuroimmunomodulation, Confounding Factors, Epidemiologic, Enteric Nervous System, Disease Progression, Evidence-Based Medicine, Neurodegenerative Diseases, Biomedical Research, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
![Figure 1 Methodical approach of systematic review due to PRISMA criteria (PRISMA criteria [33]).](https://figures.cochat.ai/paper-figures/9b939278a136418e9a3ebbc4669d8e86/changes-of-colonic-bacterial-composition-in-parkinson-s-disease-and-other-figure-1.jpg)